STEGLUJAN
STEGLUJAN
Discontinued
DIN Number
02475928
Drug Class
Human
Market Date
Jun 13, 2018
Company
HC
Merck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02475928
AIG Number0260270002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BD COMBINATIONS OF ORAL BLOOD GLUCOSE LOWERING DRUGS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.05
Health Canada Classification
ACTIVE INGREDIENTS (2)
ERTUGLIFLOZINActive
Strength: 15 MG
Monograph: ERTUGLIFLOZIN
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE)Active
Strength: 100 MG
Monograph: SITAGLIPTIN (SITAGLIPTIN PHOSPHATE)